Family Medicine Doctors in Le Claire, IA Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Michelle M Sprengelmeyer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 S Cody Rd, Le Claire, IA 52753 Phone: 563-421-9740 Fax: 563-421-9769 |
 Warne Franklin Ramsey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3238 Woodland Dr, Le Claire, IA 52753 Phone: 563-332-4561 |
Charles A Smith, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 S Cody Rd, Le Claire, IA 52753 Phone: 563-289-3008 Fax: 563-289-3024 |
Kristin A Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 S Cody Rd, Le Claire, IA 52753 Phone: 563-289-2273 Fax: 563-289-1605 |
News Archive
Cubist to oppose Teva's attempt to add new defense in patent infringement litigation
Cubist Pharmaceuticals, Inc. today announced that it will oppose a motion filed by the Teva defendants to amend their answer to add a new defense in the patent litigation between Cubist and Teva pending in the US District Court for the District of Delaware. A motion for leave to amend the answer is a request to be permitted to add a new allegation. The Teva defendants seek leave to amend their answer to allege that US Patent Nos. 6,468,967 and 6,852,689 are unenforceable due to inequitable conduct.
Terminally ill patients with certain subtypes of delirium show higher probability of imminent death
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
FDA grants Angiochem's ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme
Angiochem announced today that the Food & Drug Association (FDA) has granted both orphan drug and fast track designation to ANG1005 a novel paclitaxel-peptide drug conjugate leveraging the low density lipoprotein receptor-related protein 1 (LRP-1) pathway to cross the blood-brain barrier (BBB) and enter cancer, for the treatment of glioblastoma multiforme (GBM).
Sphere Medical to discuss potential application of Proxima at Symposium Intensivmedizin + Intensivpflege 2016
Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, announces that at the Symposium Intensivmedizin + Intensivpflege 2016, it will be discussing the potential application of its newly introduced Proxima patient-dedicated blood gas analyser with isolation beds during outbreaks of infections, such as winter influenza, MRSA and VRE.
› Verified 7 days ago